Mereo BioPharma Group plc
MREO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719714
No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Mereo BioPharma Group plc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- −3 vs. Q4 2022
- Shares held
- 60.8M
- −763.0K (−1.2%) vs. Q4 2022
- Total value
- $43.0M
- −$3.16M (−6.8%) vs. Q4 2022
- New holders
- 7
- 15 more added
- Sold out
- 10
- 14 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MREO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $18.0M |
| Q1 2026 | 63 | $24.9M |
| Q4 2025 | 70 | $25.8M |
| Q3 2025 | 84 | $206.7M |
| Q2 2025 | 86 | $267.8M |
| Q1 2025 | 90 | $250.3M |
| Q4 2024 | 91 | $403.1M |
| Q3 2024 | 77 | $434.8M |
| Q2 2024 | 79 | $361.9M |
| Q1 2024 | 80 | $277.3M |
| Q4 2023 | 64 | $181.4M |
| Q3 2023 | 56 | $90.4M |
| Q2 2023 | 53 | $84.3M |
| Q1 2023 | 58 | $43.0M |
| Q4 2022 | 61 | $46.2M |
| Q3 2022 | 63 | $58.5M |
| Q2 2022 | 64 | $82.7M |
| Q1 2022 | 60 | $99.9M |
| Q4 2021 | 73 | $145.7M |
| Q3 2021 | 63 | $212.2M |
| Q2 2021 | 72 | $284.4M |
| Q1 2021 | 67 | $304.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Mereo BioPharma Group plc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 29 | $0 | 0.00% | −1−3.3% | Reduced |
| US Bancorp | 13 | $9 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 48 | $34 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 229 | $162 | 0.00% | −1−0.4% | Reduced |
| New England Capital Financial Advisors LLC | 300 | $213 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 561 | $397 | 0.00% | 00.0% | Unchanged |
| Sit Investment Associates Inc | 970 | $1.00K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1,500 | $1.06K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 4,000 | $2.83K | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 7,000 | $4.95K | 0.00% | +3,000+75.0% | Added |
| Group One Trading, L.P. | 8,130 | $5.75K | 0.00% | −36,944−82.0% | Reduced |
| Morgan Stanley | 9,019 | $6.38K | 0.00% | −18,430−67.1% | Reduced |
| CSS LLC | 10,735 | $7.59K | 0.00% | 00.0% | Unchanged |
| Golden State Equity Partners | 14,400 | $10.2K | 0.01% | +14,400 | New |
| Level Four Advisory Services, LLC | 20,000 | $14.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 21,183 | $15.0K | 0.00% | −46,347−68.6% | Reduced |
| Resources Investment Advisors, LLC. | 21,962 | $15.5K | 0.00% | +21,962 | New |
| Oppenheimer & Co Inc | 24,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| Centiva Capital, LP | 25,000 | $17.8K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 38,320 | $27.1K | 0.00% | +12,500+48.4% | Added |
| Susquehanna International Group, LLP | 43,089 | $30.5K | 0.00% | +29,989+228.9% | Added |
| PFG Investments, LLC | 47,500 | $33.6K | 0.01% | +47,500 | New |
| HSBC Holdings PLC | 58,217 | $40.9K | 0.00% | 00.0% | Unchanged |
| Bessemer Group Inc | 58,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 58,718 | $41.5K | 0.00% | +58,718 | New |
| Worth Venture Partners, LLC | 76,513 | $54.1K | 0.03% | +76,513 | New |
| Clear Harbor Asset Management, LLC | 80,754 | $57.1K | 0.01% | −3,246−3.9% | Reduced |
| Forefront Analytics, LLC | 83,700 | $59.2K | 0.03% | +10,200+13.9% | Added |
| Jane Street Group, LLC | 91,093 | $64.4K | 0.00% | −101,869−52.8% | Reduced |
| UBS Group AG | 96,157 | $68.0K | 0.00% | −32,384−25.2% | Reduced |
| Geode Capital Management, LLC | 96,630 | $68.3K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 160,600 | $113.5K | 0.00% | +4,600+2.9% | Added |
| Privium Fund Management (UK) Ltd | 177,200 | $131.1K | 0.10% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 191,899 | $134.0K | 0.00% | +191,899 | New |
| Barclays PLC | 190,007 | $134.3K | 0.00% | +23,366+14.0% | Added |
| Primecap Management Co | 296,530 | $209.6K | 0.00% | −700−0.2% | Reduced |
| Formidable Asset Management, LLC | 331,914 | $234.0K | 0.05% | +43,834+15.2% | Added |
| Toroso Investments, LLC | 331,914 | $235.0K | 0.01% | +18,786+6.0% | Added |
| JPMorgan Chase & Co | 427,133 | $302.0K | 0.00% | +281,874+194.0% | Added |
| Boothbay Fund Management, LLC | 427,403 | $302.1K | 0.01% | +427,403 | New |
| J. Goldman & Co LP | 607,500 | $429.4K | 0.02% | +297,000+95.7% | Added |
| Renaissance Technologies LLC | 915,909 | $647.0K | 0.00% | −341,460−27.2% | Reduced |
| DAFNA Capital Management LLC | 1,096,513 | $775.1K | 0.23% | 00.0% | Unchanged |
| Citigroup Inc | 1,130,650 | $799.3K | 0.00% | +1,129,103+72,986.6% | Added |
| Monaco Asset Management SAM | 1,316,245 | $930.5K | 0.42% | −733,416−35.8% | Reduced |
| Tekla Capital Management LLC | 1,551,082 | $1.10M | 0.04% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 2,000,000 | $1.41M | 0.13% | +1,875,000+1,500.0% | Added |
| Clearline Capital LP | 2,052,709 | $1.45M | 0.22% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,250,000 | $1.59M | 0.08% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 2,262,785 | $1.60M | 0.00% | −31,981−1.4% | Reduced |
| Alkeon Capital Management LLC | 2,385,600 | $1.69M | 0.01% | +250,000+11.7% | Added |
| Tejara Capital Ltd | 2,435,806 | $1.72M | 0.88% | +247,200+11.3% | Added |
| Millennium Management LLC | 2,505,630 | $1.77M | 0.00% | +1,194,281+91.1% | Added |
| Citadel Advisors LLC | 3,047,960 | $2.15M | 0.00% | −14,372−0.5% | Reduced |
| Rock Springs Capital Management LP | 6,244,897 | $4.41M | 0.11% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 7,364,438 | $5.21M | 0.25% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 7,747,891 | $5.48M | 0.11% | −2,857,631−26.9% | Reduced |
| Rubric Capital Management LP | 10,366,120 | $7.33M | 0.29% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −132,784−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −72,740−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −37,367−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,745−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,129−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,190−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −358−100.0% | Sold out |